Visiopharm
PrivateLast Round
VC Round
Sep 1, 2020
Company Overview
Visiopharm is a decision/risk analysis company that provides AI-driven precision pathology software for research and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Visiopharm Comps
Public and private peers based on sector, stage, and business model.
Visiopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 1, 2020 | ||||
| VC Round | Aug 24, 2018 | ||||
| Private Equity | Oct 5, 2007 |
Key People
Founding team and executive leadership
Visiopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BankInvest | VC Round |
| Northcap Partners | VC Round, Private Equity |
| The Export and Investment Fund of Denmark | VC Round |
| ATP | VC Round |
| C.L. Davids Fond og Samling | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 106% MoM, reaching 9K.
- May 3, 2025
Monthly visitors increased 59% MoM, reaching 5.9K.
Visiopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Visiopharm's valuation, stock price, and market status.
